END OF SUMMER SALE NOW LIVE! USE CODE SUMMER20 FOR 20% OFF!
Each batch undergoes rigorous HPLC and MS analysis, ensuring exceptional quality and precision.
CategoriesSwipe to browse
Showing 10 results
-20%A secretagogue research blend combining a short-acting GHRH analog with a selective ghrelin receptor agonist. Studied in pulsatile GH signaling and pituitary stimulation models.
-20%Combines Tesa, a stabilized GHRH analog, with Ipa, a selective GHSR agonist. Used in research models studying GH release and neuroendocrine regulation.
-20%A multi-pathway research blend targeting GHRH signaling, ghrelin receptor activation and growth-factor splice-variant pathways. Studied in tissue remodeling and cellular signaling research.
-20%A complex secretagogue and regenerative signaling blend combining GHSR agonism, GHRH pathway activation, and MGF research targets. Intended for advanced studies involving GH pulsatility, repair signaling, and cellular adaptation.
-20%A long-acting GHRH analog with an extended half-life. Studied for sustained GH-axis activity and prolonged pituitary receptor stimulation in laboratory models.
-20%A short-acting GHRH analog studied for pulsatile growth hormone release and pituitary GH-axis signaling. Unlike DAC-modified versions, it is typically researched for shorter-duration receptor activation.
Out of stockCombines GHRH receptor activation with selective ghrelin receptor agonism. Studied for GH pulse amplification and pituitary signaling in laboratory models.
-20%A selective ghrelin receptor agonist studied for growth hormone secretagogue activity with minimal prolactin or cortisol pathway activation in research models.
